共 160 条
[1]
Tanderup K(2016)Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer Radiother Oncol 120 441-446
[2]
Fokdal LU(2014)Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma J Pathol 232 386-390
[3]
Sturdza A(2010)National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers Clin Chem 56 e1-48
[4]
Haiemeder C(2016)Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: a retrospective cohort study Int J Surg 30 121-125
[5]
Mazeron R(2012)Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria Eur J Cancer 48 2353-2360
[6]
Van LE(2014)Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer J Gynecol Oncol 25 249-259
[7]
Caffarel MM(2002)SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix Eur J Cancer 38 1987-1991
[8]
Coleman N(2016)Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation Obstet Gynecol Sci 59 269-20
[9]
Sturgeon C(2008)The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature Crit Rev Oncol Hematol 66 10-1462
[10]
Duffy M(2005)Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer J Clin Oncol 23 1455-5115